Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology

Our inheritance, our future: realising the potential of genetics in the National Health Service http://www.dh.gov.uk/assetRoot/04/01/92/39/04019239.pdf.

Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet 2001;357:709–12.

Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390–5.

Cappuccio FP. Commentary: epidemiological transition, migration, and cardiovascular disease. Int J Epidemiol 2004;33:387–8.

Collins FS. The case for a US prospective cohort study of genes and environment. Nature 2004;429:475–7.

Barbour V. UK Biobank: a project in search of a protocol? Lancet 2003;361:1734–8.

Potter JD. Toward the last cohort. Cancer Epidemiol Biomarkers Prev 2004;13:895–7.

Cyranoski D, Williams R. Health study sets sights on a million people. Nature 2005;434:812.

Schulte PA, Perera FP. Molecular epidemiology: principles and practice. San Diego, CA, USA: Academic Press, Inc.; 1993.

David RE, Staudt LM. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr Opin Hematol 2002;9:333–8.

Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002;30:41–7.

Caporaso NE. Why have we failed to find the low penetrance genetic constituents of common cancers? Cancer Epidemiol Biomarkers Prev 2002;11:1544–9.

Rebbeck TR, Martinez ME, Sellers TA, Shields PG, Wild CP, Potter JD. Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev 2004;13:1985–6.

Kennedy GC, Matsuzaki H, Dong SL, et al. Large-scale genotyping of complex DNA. Nat Biotechnol 2003;21:1233–7.

Vineis P. A self-fulfilling prophecy: are we underestimating the role of the environment in gene-environment interaction research? Int J Epidemiol 2004;33:945–6.

Wild CP, Turner PC. The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis 2002;17:471–81.

IARC. Monographs on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori. Vol. 61. Lyon, France: IARC; 1994.

Poirier MC. Chemical-induced DNA damage and human cancer risk. Nat Rev Cancer 2004;4:630–7.

Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733–44.

Groopman JD, Kensler TW. The light at the end of the tunnel for chemical-specific biomarker: daylight or headlight? Carcinogenesis 1999;20:1–11.

Qian GS, Ross RK, Yu MC, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, Peoples Republic of China. Cancer Epidemiol Biomarkers Prev 1994;3:3–10.

Wang LY, Hatch M, Chen CJ, et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 1996;67:620–5.

Tang DL, Phillips DH, Stampfer M, et al. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res 2001;61:6708–12.

Gan JP, Skipper PL, Gago-Dominguez M, et al. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst 2004;96:1425–31.

Carmella SG, Chen M, Yagi H, Jerina DM, Hecht SS. Analysis of phenanthrols in human urine by gas chromatography-mass spectrometry: potential use in carcinogen metabolite phenotyping. Cancer Epidemiol Biomarkers Prev 2004;13:2167–74.

Terasaka S, Aita Y, Inoue A, et al. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect 2004;112:773–81.

Amundson SA, Do KT, Shahab S, et al. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res 2000;154:342–6.

Amundson SA, Grace MB, McLeland CB, et al. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res 2004;64:6368–71.

Lampe JW, Stepaniants SB, Mao M, et al. Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004;13:445–53.

Nylund R, Leszczynski D. Proteomics analysis of human endothelial cell line EA.hy926 after exposure to GSM 900 radiation. Proteomics 2004;4:1359–65.

Dettmer K, Hammock BD. Metabolomics — A new exciting field within the “omics” sciences. Environ Health Perspect 2004;112:A396–7.

Wang YL, Holmes E, Nicholson JK, et al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci U S A 2004;101:12676–81.

Solanky KS, Bailey NJC, Beckwith-Hall BM, et al. Application of biofluid H-1 nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal Biochem 2003;323:197–204.

Davis CD, Milner J. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat Res 2004;551:51–64.

Weis BK, Balshaw D, Barr JR, et al. Personalized exposure assessment: promising approaches for human environmental health research [cited 2005 March 3]. doi:10.1289/ehp.7651. Available from: .